Clinical Trial Results: Positive or negative results from clinical trials directly impact investor confidence and stock price. Positive results generally lead to price increases, while negative results can cause significant drops. Regulatory Approvals: Approval or rejection of Oncocyte Corporation's products by regulatory bodies like the FDA has a major influence. Approvals typically boost the stock, whereas rejections can lead to declines. Market Conditions: Overall market sentiment and economic conditions play a role. A bullish market often lifts most stocks, while a bearish one can depress them, regardless of company performance. Company Financial Performance: Oncocyte's revenue, earnings, and cash flow are crucial. Strong financial performance usually supports a higher stock price, while weak results can have the opposite effect. Competition: The competitive landscape within the diagnostics and cancer testing industry affects Oncocyte. New products or advances from competitors can negatively impact ONCY's stock price. Partnerships and Acquisitions: Announcements of strategic partnerships or acquisitions can significantly move the stock. Positive collaborations or acquisitions are generally viewed favorably by investors. Analyst Ratings: Recommendations and price targets from financial analysts influence investor perception. Upgrades typically lead to price increases, while downgrades often result in price declines. News and Media Coverage: News articles, press releases, and media coverage about Oncocyte can impact investor sentiment and stock price. Positive coverage can attract investors, while negative coverage can deter them.